Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
November 05, 2010Trials and PIs with Dr Michael Gibson #16: ANTIPAF with Dr Andreas Goette5 minutesPlayDr Andreas Goette (Otto-von-Guericke-University Hospital, Magdeburg, Germany) discusses ANTIPAF: angiotensin II-antagonist in paroxysmal atrial fibrillation trial.Recorded at the ESC convention center in Stockholm, Sweden on Tuesday, August 31....moreShareView all episodesBy theheart.orgNovember 05, 2010Trials and PIs with Dr Michael Gibson #16: ANTIPAF with Dr Andreas Goette5 minutesPlayDr Andreas Goette (Otto-von-Guericke-University Hospital, Magdeburg, Germany) discusses ANTIPAF: angiotensin II-antagonist in paroxysmal atrial fibrillation trial.Recorded at the ESC convention center in Stockholm, Sweden on Tuesday, August 31....moreMore shows like Trials and PIs with Dr Michael GibsonView allDiscussions about Cardiology from theheart.org2 ListenersFellows’ corner on theheart.org3 ListenersL’interview minute en cardiologie0 ListenersRendez-vous éditoriaux0 ListenersLife and Times0 ListenersDigital Man0 ListenersMayo Clinic Talks5 ListenersCardiology in India0 Listeners
Dr Andreas Goette (Otto-von-Guericke-University Hospital, Magdeburg, Germany) discusses ANTIPAF: angiotensin II-antagonist in paroxysmal atrial fibrillation trial.Recorded at the ESC convention center in Stockholm, Sweden on Tuesday, August 31.
November 05, 2010Trials and PIs with Dr Michael Gibson #16: ANTIPAF with Dr Andreas Goette5 minutesPlayDr Andreas Goette (Otto-von-Guericke-University Hospital, Magdeburg, Germany) discusses ANTIPAF: angiotensin II-antagonist in paroxysmal atrial fibrillation trial.Recorded at the ESC convention center in Stockholm, Sweden on Tuesday, August 31....more
Dr Andreas Goette (Otto-von-Guericke-University Hospital, Magdeburg, Germany) discusses ANTIPAF: angiotensin II-antagonist in paroxysmal atrial fibrillation trial.Recorded at the ESC convention center in Stockholm, Sweden on Tuesday, August 31.